- Home
- Companies
- Jant Pharmacal Corporation
- Products
- OPTIGEN - Model AP3600 - Automated In ...
OPTIGEN - Model AP3600 -Automated In Vitro Allergy Diagnostic System
The OPTIGEN AP3600 Allergy Diagnostic System is A front-line solution for multiplex allergen-specific IgE testing in High-Volume Moderately Complex Laboratories. The system is fully automated and requires only the initial setup performed by the laboratory technician: prepare the patient samples, load the samples into the AP3600 Allergy Diagnostic System, and load the required OPTIGEN pettes. Each pette contains up to 36 different allergens which are tested simultaneously. The entire process takes less than six hours. Manufactured by Minaris Medical.
The AP3600™ Automated Instrument is a fully automated system that works with OPTIGEN® to offer the following benefits:
HIGH THROUGHPUT AUTOMATION
- Fully automates the OPTIGEN® assay from sample tube to result
- Process 50 panels per run (36 allergens per panel)
- Process up to 100 panels per day (3,600 test results)
- 100 patient samples, 3,600 allergen tests require only the size of a shoe box, one single part number and one expiration date
EASE OF OPERATION
- Automatically calculates reagent volume requirements
- Operator checklist for all loaded components verified by the instrument prior to run
- No calibration curve required – streamlines pre-analytical process
- Automatic pre-run check, no daily calibration
PRE-CONFIGURED PANELS
- Simplified selection of allergens for non-allergists
- Comprehensive pre-configured panels (Inhalant 36 & food 25)
- For in vitro diagnostic (IVD) use
BETTER INVENTORY MANAGEMENT
- Less risk for scrapping reagents – single expiration date
- Simple procurement – single part number for test panel
- Less space required to store reagents
DESIGN FEATURES AND OTHER BENEFITS
- Intuitive touchscreen user interface
- Two-way LIS connectivity
- Sample/result identification with internal barcode system
- Small sample volume – only 0.7 ml/test for 36 allergens (20µl/allergen)
- Competitive per-allergen cost